BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26929572)

  • 1. Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized Rats.
    Kalshetti PB; Alluri R; Mohan V; Thakurdesai PA
    Pharmacogn Mag; 2015 Oct; 11(Suppl 3):S388-96. PubMed ID: 26929572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social isolation differentially affects anxiety and depressive-like responses of bulbectomized mice.
    Linge R; Pazos Á; Díaz Á
    Behav Brain Res; 2013 May; 245():1-6. PubMed ID: 23416113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats.
    Rinwa P; Kumar A
    Neuroscience; 2013; 255():86-98. PubMed ID: 24095694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treadmill exercise improves depression-like symptoms by enhancing serotonergic function through upregulation of 5-HT
    Shin MS; Park SS; Lee JM; Kim TW; Kim YP
    J Exerc Rehabil; 2017 Feb; 13(1):36-42. PubMed ID: 28349031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine- and amphetamine-regulated transcript peptide plays a role in the manifestation of depression: social isolation and olfactory bulbectomy models reveal unifying principles.
    Dandekar MP; Singru PS; Kokare DM; Subhedar NK
    Neuropsychopharmacology; 2009 Apr; 34(5):1288-300. PubMed ID: 19005467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy.
    Padilla KM; Quintanar-Setephano A; López-Vallejo F; Berumen LC; Miledi R; García-Alcocer G
    Brain Behav; 2018 May; 8(5):e00952. PubMed ID: 29761007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety.
    Mar A; Spreekmeester E; Rochford J
    Pharmacol Biochem Behav; 2002 Oct; 73(3):703-12. PubMed ID: 12151047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression.
    Rinwa P; Kumar A; Garg S
    PLoS One; 2013; 8(4):e61052. PubMed ID: 23613781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory bulbectomy induces rapid and stable changes in basal and stress-induced locomotor activity, heart rate and body temperature responses in the home cage.
    Vinkers CH; Breuer ME; Westphal KG; Korte SM; Oosting RS; Olivier B; Groenink L
    Neuroscience; 2009 Mar; 159(1):39-46. PubMed ID: 19136045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.
    Wang YQ; Tu ZC; Xu XY; Li R; Qu WM; Urade Y; Huang ZL
    J Neurochem; 2012 Jan; 120(2):314-24. PubMed ID: 22035172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
    Sato H; Skelin I; Debonnel G; Diksic M
    Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
    Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
    Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
    Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
    Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study.
    van der Stelt HM; Breuer ME; Olivier B; Westenberg HG
    Biol Psychiatry; 2005 May; 57(9):1061-7. PubMed ID: 15860347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.
    Jindal A; Mahesh R; Bhatt S
    Psychopharmacology (Berl); 2015 Feb; 232(3):623-37. PubMed ID: 25120105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory bulbectomy increases reinstatement of methamphetamine seeking after a forced abstinence in rats.
    Babinska Z; Ruda-Kucerova J; Amchova P; Merhautova J; Dusek L; Sulcova A
    Behav Brain Res; 2016 Jan; 297():20-7. PubMed ID: 26431766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.
    Amchova P; Kucerova J; Giugliano V; Babinska Z; Zanda MT; Scherma M; Dusek L; Fadda P; Micale V; Sulcova A; Fratta W; Fattore L
    Front Pharmacol; 2014; 5():44. PubMed ID: 24688470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic-pituitary-adrenal axis, cAMP signaling aspects and antioxidant defense system.
    Jindal A; Mahesh R; Bhatt S
    Pharmacol Biochem Behav; 2015 May; 132():20-32. PubMed ID: 25712174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
    Breuer ME; van Gaalen MM; Wernet W; Claessens SE; Oosting RS; Behl B; Korte SM; Schoemaker H; Gross G; Olivier B; Groenink L
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):101-6. PubMed ID: 18668225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhodioloside ameliorates depressive behavior via up-regulation of monoaminergic system activity and anti-inflammatory effect in olfactory bulbectomized rats.
    Zhang X; Du Q; Liu C; Yang Y; Wang J; Duan S; Duan J
    Int Immunopharmacol; 2016 Jul; 36():300-304. PubMed ID: 27214337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.